We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMDC
RNS Number : 9223H
Mediclinic International plc
20 November 2018
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
20 November 2018
Notification of Major Interest in Mediclinic International plc shares
Hot Features
Premium
1a. Identity of the issuer or the Mediclinic International plc
underlying issuer of existing shares
to which voting rights are attached:
------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify):
----
3. Details of person subject to the notification obligation
Name Coronation Asset Management (Pty)
Ltd acting as discretionary investment
manager on behalf of managed portfolios.
City and country of registered office Cape Town, South Africa
(if applicable)
4. Full name of shareholder(s) (if different from 3.)
Name N/A
------------------------------------------------
City and country of registered office
(if applicable)
------------------------------------------------
5. Date on which the threshold was 20/11/2018
crossed or reached:
------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 20/11/2018
------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ----------------------- ---------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 4.06% 4.06% 737 243 810
------------------ ----------------------- ---------------- --------------------
Position of
previous notification
(if
applicable) 3.98% 3.98%
------------------ ----------------------- ---------------- --------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
----------------------------
GB00B8HX8Z88 29 909 882 4.06%
---------------------- ---------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 29 909 882 4.06%
---------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument be acquired if
the instrument
is
exercised/converted.
------------ ------------------------------- -------------------------------- ---------------------
SUBTOTAL 8. B 1
------------------------------- -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date Conversion cash voting rights rights
instrument Period settlement
----------------- -------------------- --------------------- --------------------
SUBTOTAL 8.B.2
--------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary)
Name % of voting % of voting rights Total of both if
rights if it through financial it equals or is
equals or is instruments if higher than the
higher than it equals or notifiable threshold
the notifiable is higher than
threshold the notifiable
threshold
---------------- ------------------- ------------------------
Coronation Fund Managers
Ltd
---------------- ------------------- ------------------------
Coronation Investment
Management SA (Pty) Ltd
---------------- ------------------- ------------------------
Coronation Asset Management
(Pty) Ltd 4.06% 4.06%
---------------- ------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
---------------------------------------------
The number and % of voting rights held
---------------------------------------------
The date until which the voting rights
will be held
---------------------------------------------
11. Additional information
Place of completion Cape Town, South Africa
Date of completion 20/11/2018
------------------------
Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLUROARWNAAUAA
(END) Dow Jones Newswires
November 20, 2018 08:00 ET (13:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
